Status:
COMPLETED
Role of Antioxidants (Vitamin C and E) in the Management of Schizophrenia
Lead Sponsor:
University of Health Sciences Lahore
Conditions:
Schizophrenia
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
Background: Antioxidants are substances that are considered as a defensive material which protects cells from destruction. It is evident that use of food stuff rich in antioxidant will fortify one's a...
Detailed Description
Background: Antioxidants such as Vitamin C and E are substances that are considered as a defensive material which protects cells from destruction. It is evident that use of food stuff rich in antioxid...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- All diagnosed schizophrenic patients 20-50 years of age
- visited department of psychiatry \& behavioral sciences King Edward medical university Lahore.
- EXCLUSION CRITERIA:
- Patients diagnosed with axis i and axis ii disorders
- having any other pathological condition like hypertension, hyperlipidemia, and cardiac disorders.
Exclusion
- \-
Key Trial Info
Start Date :
April 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2017
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT04078048
Start Date
April 27 2017
End Date
November 15 2017
Last Update
September 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saima Kouser
Lahore, Punjab Province, Pakistan, 54000